Xylosyltransferase activity in diabetes mellitus Serum xylosyltransferase activity in diabetes mellitus patients as a possible marker of reduced proteoglycan biosynthesis

Serum xylosyltransferase activity in diabetes mellitus patients as a possible marker of reduced proteoglycan biosynthesis Christian Götting, PhD; Joachim Kuhn, PhD; Knut Kleesiek, MD Institut für Laboratoriumsund Transfusionsmedizin, Herzund Diabeteszentrum NordrheinWestfalen, Universitätsklinik der Ruhr-Universität Bochum, Bad Oeynhausen, Germany; Corresponding author Christian Götting, E-mail: [email protected] Received 16 May 2008 and accepted 16 July 2008 This is an uncopyedited electronic version of an article accepted for publication in Diabetes Care. The American Diabetes Association, publisher of Diabetes Care, is not responsible for any errors or omissions in this version of the manuscript or any version derived from it by third parties. The definitive publisherauthenticated version will be available in a future issue of Diabetes Care in print and online at http://care.diabetesjournals.org. Diabetes Care Publish Ahead of Print, published online July 23, 2008